v3.22.1
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating expenses:    
Research and development $ 9,170 $ 6,556
General and administrative 3,829 3,156
Total operating expenses 12,999 9,712
Loss from operations (12,999) (9,712)
Other income:    
Interest income 53 10
Net loss (12,946) (9,702)
Other comprehensive income:    
Net unrealized loss on available-for-sale investments, net of tax (152) (3)
Net comprehensive loss $ (13,098) $ (9,705)
Net loss per share of voting and non-voting common stock, basic and diluted $ (0.45) $ (0.41)

Source